Aurobindo adds Apotex to gain OTC clout in EU
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
India’s Aurobindo is set to expand its European OTC footprint by signing a definitive agreement to acquire for €74 million in cash Apotex’ businesses in five countries: Belgium, the Czech Republic, the Netherlands, Poland and Spain.